Dublin, OH, Oct. 23, 2025 (GLOBE NEWSWIRE) — As temperatures drop and families spend more time indoors, Stanley Steemer, the leader in professional deep home cleaning, is helping homeowners breathe easier with a Whole-Home UV Air Purification System. Installed directly within a home's HVAC system, the in-duct ultraviolet purifier uses advanced UV technology to neutralize […]

Oakland, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) — Great Place To Work(R) and Fortune have released the winners of the 2025 Fortune Best Workplaces for Women(TM) List. Great Place To Work analyzed survey responses from nearly 605,000 women who work for Great Place To Work Certified(TM) companies that were eligible for the list. To be

Appointments for SVP of Clinical Operations, VP of Translational Science, and Head of Project and Portfolio Management will strengthen Amphista's clinical development capabilities and accelerate its ambition to bring its innovative Targeted Glue(TM) protein degraders to patients Cambridge, UK, 23 October 2025 – Amphista Therapeutics, a leader in the discovery of next-generation, Targeted Protein Degradation

GMRx2 significantly reduced the risk of recurrent stroke when added to standard of care compared to placebo Trial results were presented during a plenary session of the World Stroke Congress 2025 in Barcelona London, UK, Boston, MA, 23 October 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs in cardiometabolic

(NASDAQ:MRX), NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) — Marex Group plc (NASDAQ: MRX) today announced that it will release its fiscal 2025 third quarter results before market open on Thursday, November 6, 2025. The earnings release and supplementary materials will be available through the “Investors” section of the Marex website at https://ir.marex.com/. A conference

(NasdaqGM:EDAP), EDAP to Announce Third Quarter 2025 Financial Results on November 6, 2025 Company to host conference call and webcast on Thursday, November 6th at 8:30am EST AUSTIN, Texas, October 23, 2025 — EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial

(NasdaqGM:AEBI), FRAUENFELD, Switzerland, Oct. 23, 2025 (GLOBE NEWSWIRE) — Aebi Schmidt Group (NASDAQ: AEBI) (“Aebi Schmidt” or the “Company”), a world-class specialty vehicles leader, today announced that its Board of Directors has declared a quarterly dividend, and the Company will host its third quarter 2025 earnings conference call and webcast on November 13, 2025. Quarterly

Reqorsa® Gene Therapy is a Potential Treatment for ALK-EML4 Positive Translocated Non-Small Cell Lung Cancer Research Suggests that REQORSA May Be an Effective Treatment in Patients Progressing on Alectinib Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced

CatalystBancorp, Inc. (Nasdaq: “CLST”) (the “Company”), the parent company for Catalyst Bank (the “Bank”) (www.catalystbank.com), reported net income of $489,000 for the third quarter of 2025, compared to net income of $521,000 for the second quarter of 2025. https://mma.prnewswire.com/media/1774086/Catalyst_Bancorp_Logo.jpg “Our team has done a good job attracting new deposit customers in 2025,” said Joe Zanco,

Civista Bancshares, Inc. (NASDAQ:CIVB) (“Civista”) today reported net income of $12.8 million, or $0.68 per common share, for the quarter ended September 30, 2025. https://mma.prnewswire.com/media/241852/civista_bancshares_logo.jpg — Completed an underwritten public offering of common stock, including an overallotment option. The offering totaled 3,788,238 shares at a price of $21.25 per share, raising approximately $80,500,058. — Net